首页> Leukemia & lymphoma> Achievement of durable remission of relapsed/refractory acute myeloid leukemia in a child using venetoclax monotherapy.

Achievement of durable remission of relapsed/refractory acute myeloid leukemia in a child using venetoclax monotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Juanita E,Ferreira

第一单位： Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.

作者： Juanita E,Ferreira ^[1] ; Cassandra P,Wang ^[2] ; Paibel,Aguayo-Hiraldo ^[3] ; Gordana,Raca ^[4] ; Chintan,Parekh ^[3] ; David R,Freyer ^[3] ; Alexandra E,Kovach ^[5]

作者单位： Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA. ^[1] Department of Pediatrics, Hematology/Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA. ^[2] Department of Pediatrics, Hematology/Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. ^[3] Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.;Department of Pathology and Laboratory Medicine, Cytogenomics, Center for Personalized Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA. ^[4] Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. ^[5]

DOI 10.1080/10428194.2025.2482135

PMID 40129388

发布时间 2025-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交